Corrigendum à « Troubles urinaires et génito-sexuels dans le syndrome d’apnée obstructive du sommeil : revue de la littérature » [Prog. Urol. 30 (2020), 1069–1077]

Clerget, A.; Kanbar, Anthony; Abdessater, Maher

doi:10.1016/j.purol.2020.12.017

Cited by 1 publication

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies have reported an association between erectile dysfunction (ED) and obstructive sleep apnea (OSA) [ 21 , 26 , 27 , 28 ].…”

Section: Discussionmentioning

confidence: 99%

“…Several studies have examined the effects of continuous positive airway pressure (CPAP) on ED in OSA patients, with mixed results [ 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 ]. CPAP may improve erectile function by reducing nocturnal hypoxia, decreasing sympathetic activation, increasing nitric oxide levels, and restoring endothelial function [ 22 ].…”

Section: Discussionmentioning

confidence: 99%

“…Similarly, OSAS has been associated with other relevant conditions such as nocturia and lower urinary tract symptoms (LUTS), which should also be incorporated into future research as they could help increase the comprehensiveness of the evidence [ 28 , 29 ].…”

Section: Discussionmentioning

confidence: 99%

“…A study by Clerget et al investigated the effects of continuous positive airway pressure (CPAP) therapy on LUTS in male patients with OSAS [ 28 ]. The results demonstrated that CPAP treatment significantly improved LUTS, including nocturia, in these patients, suggesting a potential link between the two conditions.…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Is Continuous Positive Airway Pressure a Valid Alternative to Sildenafil in Treating Sexual Dysfunction among OSA Patients? A Systematic Review and Meta-Analysis

et al. 2023

View full text Add to dashboard Cite

Background and Objectives: This study aimed to assess the comparative effectiveness of continuous positive airway pressure (CPAP) therapy and sildenafil pharmacological therapy in improving sexual function among patients with obstructive sleep apnea (OSA) and erectile dysfunction (ED). Materials and methods: Population: Patients affected by OSA and ED; Intervention: CPAP therapy vs. Comparison: Sildenafil pharmacological therapy; Outcomes: Improvement in erectile function, as measured by the International Index of Erectile Function 5 (IIEF-5) scoring system; Time: A systematic review of the literature from the past 20 years; Study Design: Observational studies comparing erectile function improvements after OSA treatment. Results: A total of eight papers were included in the qualitative summary, involving four hundred fifty-seven patients with ED and OSA. Erectile function improvements were observed in both treatment groups. After sildenafil and CPAP treatment, the mean IIEF-5 domain scores were 37.7 and 27.3, respectively (p < 0.001). Sildenafil 100 mg demonstrated a higher therapeutic impact compared to CPAP treatment. Conclusions: CPAP therapy significantly improved sexual parameters in most studies for OSA patients with ED. The findings suggest that CPAP therapy effectively alleviates erectile dysfunction symptoms, resulting in improved sexual performance in OSA patients. The comparison of the two treatments indicates that sildenafil has a more substantial therapeutic impact on erectile function than CPAP therapy; however, a combined treatment will provide a cumulative effect.

show abstract

“…Several studies have reported an association between erectile dysfunction (ED) and obstructive sleep apnea (OSA) [ 21 , 26 , 27 , 28 ].…”

Section: Discussionmentioning

confidence: 99%